UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000001839
Receipt No. R000002215
Scientific Title Phase II clinical trial of personalized peptide vaccination for primary lung cancer
Date of disclosure of the study information 2009/04/05
Last modified on 2019/01/07 10:41:15

No. Disposal Last modified on Item of update
1 Insert 2009/04/01 21:06:18
2 Update 2009/04/03 20:40:18 Public title
Acronym
3 Update 2009/04/03 20:51:16 Narrative objectives1
Narrative objectives1
Basic objectives2
Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
4 Update 2009/04/03 20:58:46 Last name of lead principal investigator
Division name
Address
Address
Last name of contact person
Division name
Division name
Address
Address
Address
Address
Institute
Institute
Organization
Organization
Category of Funding Organization
Organization1
Address1
Tel1
Email1

5 Update 2009/04/03 20:59:59 Recruitment status
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
6 Update 2009/04/03 21:08:34 Basic design
Blinding
No. of arms
Type of intervention
Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
Key inclusion criteria
Key exclusion criteria
7 Update 2009/04/04 10:14:44 Classification by specialty
8 Update 2009/04/04 10:15:35 Last name of lead principal investigator
9 Update 2009/04/10 16:33:29 Recruitment status
10 Update 2011/09/26 11:30:50 UMIN ID1
11 Update 2011/09/28 10:28:03 Recruitment status
12 Update 2011/11/04 12:14:54 Last name of contact person
Name of person sending information
Name of person sending information
Organization
Division name
Division name
Email
Post marketing survey by drug manufacture etc., specified by Japanese law.
13 Update 2011/11/16 14:16:56 Public title
Public title
Acronym
Acronym
14 Update 2011/11/16 14:21:14 Condition
Condition
Narrative objectives1
Narrative objectives1
15 Update 2011/11/16 14:35:51 Key inclusion criteria
Key inclusion criteria
16 Update 2011/11/16 14:42:40 Key inclusion criteria
17 Update 2012/10/22 17:42:18 Co-sponsor
Co-sponsor
18 Update 2013/05/10 11:30:23 Recruitment status
19 Update 2014/07/07 15:10:34 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Division name
Division name
Address
Address
TEL
Email
Institute
Institute
Organization
Organization
Category of Funding Organization
Nationality of Funding Organization
Nationality of Funding Organization
20 Update 2014/07/07 15:15:26 Recruitment status
21 Update 2014/12/08 16:09:48 Key secondary outcomes
22 Update 2014/12/08 16:12:42 Interventions/Control_1

Key inclusion criteria
Key inclusion criteria
23 Update 2019/01/07 10:41:15 Recruitment status


Contact us.